Skip to main content
Mundla Srilatha on Muck Rack

Mundla Srilatha

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Mundla

Contact Mundla, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions

|
By Ganji Purnachandra Nagaraju, Seema Kumari, Batoul Farran, Rachael Guenter, Bassel F. El-Rayes, Haasita Nellipudi, Chaithanya Ganji, Vaishnavi Kuppala, Swapna Priya Ganji, Mundla Srilatha
| Nature Verified
Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal and aggressive tumor types, with a dismal 5-year survival rate of less than 15%. Despite major advances in understanding PDAC biology, therapeutic progress has been limited. Numerous preclinical studies have provided encouraging evidence that immune-based therapies may be effective.
Open in Who Shared Issue with article?
See all 1 articles